| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.049 | 0.7 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |